As the race for a novel coronavirus vaccine continues, there's growing concern from scientists and economic experts that wealthy nations are prioritizing getting doses for their own citizens at the cost of poorer nations and thus failing to control the global pandemic. In the midst of this debate
As the race for a novel coronavirus vaccine continues, there's growing concern from scientists and economic experts that wealthy nations are prioritizing getting doses for their own citizens at the cost of poorer nations and thus failing to control the global pandemic.
"The virus does not know and does not respect borders. An outbreak of the virus anywhere threatens people everywhere," Dr. Dan Barouch, professor of medicine at Harvard Medical School, told ABC News.While it's understandable for each country's"health departments to have a primary responsibly to their country's citizens," Barouch said,"each country needs to have a dual goal -- a goal of protecting their citizens and also ...
Yet, even if global cooperation is the most efficient way to halt a virus in its tracks, it's a difficult political proposition. In Europe, there is the Inclusive Vaccines Alliance which has already agreed to buy 400 million doses of AstraZeneca's vaccine being co-developed with Oxford University. That's important, because a strategy of vaccinating high-risk people first -- wherever they are -- is thought to be most effective at slowing viral transmission.
Although the World Health Organization has set up a group called the COVID-19 Vaccines Global Access, with a mission statement to guarantee"fair and equitable access for every country in the world," its lofty goals will only be realized with a formal and tangible commitment by powerful nations.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Calendar of confusion: From February to August, Trump's mixed messages on masksTrump admin's conflicting messaging about mask-wearing over the last 4 to 5 months has created widespread confusion, hampered the country's response to the coronavirus pandemic and even led to preventable deaths, multiple health experts say.
Weiterlesen »
Goldman raises economic growth outlook as it sees a vaccine approval this yearThe firm sees 'at least one' vaccine approved by the end of 2020 and hitting the market for widespread distribution by the second quarter of 2012.
Weiterlesen »
Goldman Sachs lifts 2021 US GDP forecast to 6.2% and predicts a COVID-19 vaccine will be 'widely distributed' by mid-2021 | Markets InsiderGoldman Sachs raised its 2021 US GDP forecast to 6.2% from 5.6%, driven by expectations that at least one COVID-19 vaccine will be 'widely distr...
Weiterlesen »